Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

奥美沙坦酯氨氯地平片 - NMPA Drug Approval Details

Approvals/NMPA/Olmesartan Medoxomil and Amlodipine Besylate Tablets

Approved

化学药品

Olmesartan Medoxomil and Amlodipine Besylate Tablets

重庆华森制药股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Dec 30, 2022
Approval ID: c0e2e4e122791e5b
Company: 重庆华森制药股份有限公司
Type: 化学药品

Approval Details

Approval Id: c0e2e4e122791e5b
Approval Number: 国药准字H20223939
Generic Name: 奥美沙坦酯氨氯地平片
Generic Name En: Olmesartan Medoxomil and Amlodipine Besylate Tablets
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 每片含奥美沙坦酯20mg与苯磺酸氨氯地平（按氨氯地平计）5mg
Reg Date: 2022-12-30
Company Name: 重庆华森制药股份有限公司
Company Address: 重庆市荣昌区工业园区
Production Company Name: 重庆华森制药股份有限公司
Production Company Address: 重庆市荣昌区昌州街道板桥路143号
Company Detail Path: /organization/75917e56266cb648/chongqing-pharscin-pharmaceutical-co-ltd
Production Company Detail Path: /organization/75917e56266cb648/chongqing-pharscin-pharmaceutical-co-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 30, 2022

Approval ID

c0e2e4e122791e5b

Type

化学药品

Back to NMPA Approvals